Patent ID: 8142799

Claim:
A method of administering an anti-craving medication to the body of an individual suffering from substance abuse, the method comprising: administering an anti-craving medication in an intravenous drip, wherein the anti-craving medication comprises: 7.50 grams of D-phenylalanine, 7.50 grams of L-phenylalanine, 0.05 grams of L-tyrosine, 2.4 grams of L-tryptophan, 15.0 grams of L-glutathione, 2.0 grams of folic acid, 0.4 grams of methylcobalamin, 500 grams of ascorbic acid from a beet source, 5.0 grams of thiamine hydrochloride, 0.4 grams of pyridoxal-5-phosphate monohydrate, 0.4 grams of riboflavin-5-phosphate sodium, 10.0 grams of niacinamide, 20.0 grams of dexpanthenol, 10.0 grams of inositol, 8.0 grams of magnesium chloride, 12.8 grains of zinc sulfate, 1.572 grams of cupric sulfate, 0.612 grams of manganese sulfate, 0.02052 grams of chromic chloride, 0.0392 grams of sodium selenite, and saline solution to bring the total volume to 1000 milliliters.